Method and apparatus for determination of atherosclerotic plaque type by measurement of tissue optical properties

Abstract
Methods for diagnosing vulnerable atherosclerotic plaque using optical coherence tomography to measure tissue optical properties, including backreflectance of heterogeneous layers, such as plaque cap, lipid pool composition and macrophage presence. Methods also include measurement of spatially and temporally dependent reflectance, measurement of multiple wavelength reflectance, low coherence interferometry, polarization and quantification of macrophage content.
Description
FIELD OF THE INVENTION

The present invention provides methods for characterization of atherosclerotic plaque by measurement of tissue optical properties, such as by optical coherence tomography.


BACKGROUND OF THE INVENTION

Myocardial infarction is the major cause of death in industrialized countries. Rupture of vulnerable atherosclerotic plaques is currently recognized as an important mechanism for acute myocardial infarction, which often results in sudden death. Recent advances in cardiovascular research have identified anatomic, biomechanical, and molecular features of atherosclerotic plaques that predispose them to rupture. In a majority of vulnerable plaques, these features include 1) the presence of activated macrophages at the shoulder or edge of the plaque, 2) a thin fibrous cap (<60 μm) and 3) a large lipid pool. The lipid pool is thought to apply force to the fibrous cap that causes it to become compromised. Once it is ruptured, the lipid enters the vessel lumen, causing thrombosis, arterial occlusion, myocardial ischemia, and infarction. In addition to lipid-rich plaques with a thin fibrous cap, other plaque types have been recently implicated as vulnerable plaques. These plaques contain a surface erosion where the intima has been denuded, leaving a rough surface at risk for causing platelet aggregation and acute thrombosis.


Coronary arteries that do not contain plaque have a layered structure consisting of an intima, media, and adventitia. A simple model of a lipid-rich plaque is a two layered structure consisting of a fibrous cap and an underlying lipid pool. Other atherosclerotic plaque types consist of one layer, either fibrous or calcified. Research indicates that the distinct layers present in atherosclerotic plaques have different scattering, absorption, and anisotropy coefficients. It is believed that the measurement of these parameters using light will enable characterization of plaque type in vivo and allow for the diagnosis of vulnerable plaques.


Cellularity of fibrous caps of atherosclerotic plaque, manifested by the infiltration of macrophages (average size 20-50 μm), is thought to weaken the structural integrity of the cap and predispose plaques to rupture. Macrophages, and other plaque related cells, produce proteolytic enzymes such as matrix metalloproteinases that digest extracellular matrix and compromise the integrity of the fibrous cap. Activated macrophages are strongly colocalized with local thrombi in patients who have died of acute myocardial infarction and are more frequently demonstrated in coronary artery specimens obtained from patients suffering from acute coronary syndromes compared with patients with stable angina. This evidence suggests that an imaging technology capable of identifying macrophages in patients would provide valuable information for assessing the likelihood of plaque rupture. Results from intracoronary OCT, recently performed in patients, have shown an improved capability for characterizing plaque microstructure compared with IVUS. To date, however, the use of OCT for characterizing the cellular constituents of fibrous caps has not been fully investigated.


It would be desirable to have a means for using remitted light to measure the optical properties of atherosclerotic plaques, determine plaque cap thickness or identify plaques with surface erosions and as a result assess coronary plaque vulnerability.


A method that detects plaques vulnerable to rupture could become a valuable tool for guiding management of patients at risk and may ultimately prevent acute events. Many different catheter-based methods are under investigation for the detection of vulnerable plaques. These methods include intravascular ultrasound (IVUS), optical coherence tomography (OCT), fluorescence spectroscopy, and infrared spectroscopy. While IVUS and OCT are used to obtain cross-sectional images of tissue, only OCT has been shown to have sufficient resolution to detect the presence of a thin fibrous cap. Fluorescence and infrared spectroscopy are methods that primarily detect the presence of lipids within the vessel wall. Of the four proposed techniques, only OCT has been shown to be capable of spatially resolving parameters directly responsible for plaque rupture.


Background Principles


The backreflected light scattered from within a turbid medium, such as tissue, is affected by the optical properties of the medium. The optical properties that determine the propagation of light in tissue are the absorption coefficient, μa, the scattering coefficient, μs and the total attenuation coefficient, μt, where

μtμsa

The absorption coefficient is linearly related to the concentration of the absorber, such that

μa=ε[Ab]

where ε is the molar extinction coefficient for the absorber and [Ab] is the molar concentration of the absorber.


Often, the mean cosine of the scattering phase function, g, is combined with μs to form the transport scattering coefficient:

μ′ss(1−g)


Propagation of light described using the transport scattering coefficient can be considered isotropic since the scattering coefficient has been normalized by the anisotropy coefficient, g.


Propagation of light within multiply scattering media is described by the radiative transport equation. Solutions to the radiative transport equation by use of diffusion theory approximations have allowed the use of remitted light to predict the optical properties of homogeneous highly scattering media. Application of these techniques for diagnosing neoplasia has been problematic, however, due to tissue inhomogeneities and the large depth of tissue which must be probed to identify small tumors deeply embedded in tissue. Nevertheless, in the limited setting of atherosclerotic plaques, the tissue structure is less heterogeneous and the pathology is at the surface of the vessel. These two features of arterial pathology make characterization of atherosclerotic plaques by measurement of optical properties possible.



FIGS. 1A and 1B show a schematic of the spatial remittance (r) for a fibrous plaque (FIG. 1A) and a lipid-rich plaque with a fibrous cap (FIG. 1B). The different optical properties of the two layers gives rise to a distinct remittance profile. This profile can be measured and the optical properties and thicknesses of the layers can be determined using two-layer diffusion approximation to the radiative transport equation. In FIGS. 1A and 1B, a single beam of light is incident on the sample which is depicted as a two-layer model. Diffusion of light through the media produces a spatial remittance profile that is dependent on the optical properties of the media (FIG. 1A). In FIG. 1B, i.e., the three-dimensional optical fluence is depicted as iso-contours. As can be seen in this simple schematic, the additional layer effects the spatially dependent three dimensional fluence and the remittance profile at the surface of the model. This effect is dependent on the optical properties and thicknesses of the layers and represents one method for measuring optical properties to characterize plaque composition and cap thickness. FIG. 2 shows the results of a preliminary study performed demonstrating the difference in radial remittance for different plaque types, in which Gaussian fits of the spatial remittance profiles were measured from a normal aorta and two lipid-rich plaques, one containing a thick fibrous cap and the other, a thin fibrous cap. The trend towards decreasing remittance distribution width is a result of a decrease in the amount of light scattered from the fibrous cap (λ=633 nm).


SUMMARY OF THE INVENTION

The present invention describes methods for determining the fibrous cap thickness and measuring tissue optical properties. In one embodiment of the present invention, the presence of a large lipid pool underlying the cap is measured. In another embodiment, macrophage degradation can be identified. Moreover, use of these techniques may allow determination of plaques containing surface erosions.


Several methods for measuring the optical properties of tissue can potentially be used to investigate the structure of atherosclerotic plaques. Some of the methods described below may be modified, as is known to those skilled in the art, to incorporate multiple layers. These techniques may also be used as stand-alone measurements, or in combination.


Spatially Dependent Reflectance Measurements


A single spot on the sample is irradiated with single or multiple wavelengths of light. The remitted light as a function of distance from the sample, r, is measured. Using the diffusion approximation and/or Monte Carlo simulation results, this radial remittance profile, combined with the total reflectance from the sample can yield the absorption and transport scattering coefficients of a homogenous medium. Recently, diffusion theory has been used to calculate the optical properties of a two-layered media, and determine the layer thicknesses. In addition to the tissue optical properties, the cap thickness affects this spatial remittance distribution (FIG. 2F). Fitting experimentally measured spatial remittance distributions to Monte Carlo simulations (e.g., by the Levenberg-Marquardt method) may allow for the determination of cap thickness for lipid-rich plaques.


Multiple Wavelength Reflectance Measurements


Reflectance measurements may be made using two wavelengths with different penetration depths. If absorption for the two wavelengths is similar in atherosclerotic plaques, then the ratio of the reflectances for the two wavelengths gives an estimate of cap thickness.


Low-Coherence Interferometry (LCI)


Coherence ranging in tissue has been shown to be a powerful method for calculating the optical properties of layered tissue. Multiple linear fits of the LCI axial reflectivity allows determination of the total attenuation coefficient for each layer. Transitions between different linear fits determines the layer thicknesses of the tissue.


Quantification of Macrophage Content


The present invention provides methods for quantification of macrophage content of the cap. High macrophage content is indicative of potential plaque rupture. Several algorithms are presented for determining macrophage density, including, focus tracking, correction of focus, intensity normalization, computation of macrophage density within ROI, and cluster analysis or threshold application. OCT measures the intensity of light returning from within a sample. Samples having a higher heterogeneity of optical index of refraction exhibit stronger optical scattering and therefore a stronger OCT signal. If the characteristic size scale of the index of refraction heterogeneity is larger than the resolution, then the OCT signal will have a larger variance. Previous research conducted to measure the optical properties of human tissue has shown that the refractive index of lipid and collagen is significantly different. Caps containing macrophages should have multiple strong backreflections, resulting in a relatively high OCT signal variance.


A common theme to most of the methods described herein includes the use of a single fiber to irradiate the sample and multiple (small number) of fibers for detection. One embodiment of a catheter capable of making these measurements comprises a fiber optic array (one- or two-dimensional), lens, and prism which is contained within an inner housing capable of rotation. Light from one fiber input is focused by a lens, reflected off of a prism, and directed onto the artery wall. Light reflected from the sample may be collected by other fibers in the fiber bundle. An image of the optical properties may be obtained by rotating the inner housing. Since these techniques can be implemented using fiber optics, these measurements can be made using an intravascular device.





BRIEF DESCRIPTION OF THE DRAWINGS

The various features and advantages of the invention will be apparent from the attached drawings, in which like reference characters designate the same or similar parts throughout the figures, and in which:



FIG. 1A is a schematic of the spatial remittance (r) for a fibrous plaque. FIG. 1A is the path of average photons which is affected by the scattering, absorption, and anisotropy coefficient FIG. 1B is a schematic of the spatial remittance (r) for a lipid-rich plaque with a fibrous cap. FIG. 1B is a cross-sectional view of the three-dimensional fluence (as an isocontour plot).



FIG. 2 shows Gaussian fits of the spatial remittance profiles measured from a normal aorta and two lipid-rich plaques, one containing a thick fibrous cap and the other, a thin fibrous cap.



FIG. 3 is a Monte Carlo simulation of radial remittance.



FIG. 4A is a graph of an incoming short temporal pulse.



FIG. 4B is a graph of an outgoing pulse with decay and broadening of the pulse.



FIG. 4C is a graph of an outgoing pulse reflecting off a cap with a liquid pool showing two decay curve slopes.



FIGS. 5A and B are schematic views of a generalized catheter and detector system according to an embodiment of the present invention.



FIG. 5C is a schematic view of a system having a short pulse light source and a time gated electronic.



FIGS. 6A and B show graphs of oscillating light at different amplitudes A1 and A2.



FIG. 7A cap thickness as a function of frequency (F) where two peaks ALP (amplitude of the lipid pool) and ACAP (amplitude of the cap) are related to the optical properties.



FIG. 7B shows a phase plot of the angle F as a function of φ in radians and is also dependent on cap thickness and optical properties.



FIG. 8 is a schematic view of an alternative embodiment of a system of the present invention.



FIG. 9 shows Monte Carlo wavelength ratiometric spatial reflectance distributions for two different cap thicknesses.



FIG. 10A is a histogram or probability distribution function (PDF) for different tissue regions.



FIG. 10B is an OCT image containing a lipid-rich region, a calcification, and a fibrous cap.



FIG. 10C is an OCT image showing a fibrous cap and a lipid pool with different total attenuation coefficients.



FIG. 10D is an OCT image of a large intimal calcification has a higher total attenuation coefficient than either the fibrous cap or lipid pool in FIG. 10C.



FIG. 11 shows a schematic of a polarization sensitive OCT system according to one embodiment of the present invention.



FIGS. 12A and B shows OCT images of human coronary artery plaque acquired in vivo. A. Polarization independent image shows the presence of a fibrous plaque from 11 o'clock to 8 o'clock (clockwise). B. Polarization sensitive image shows presence of bands (arrows) within the fibrous plaque.



FIGS. 13A-C show images taken using polarization sensitive OCT. FIG. 13A is an OCT polarization diversity image; FIG. 13B is a polarization sensitive image; and, FIG. 13C is the histology of the same site.



FIG. 14. A and B are graphs showing the correlation between the Raw (A) and logarithm base 10 (B) OCT NSD and CD68% area staining (diamonds—NSD data; solid line—linear fit).





DETAILED DESCRIPTION OF THE EMBODIMENTS

Spatially Dependent Reflectance



FIGS. 1A and B are schematic illustrations of the spatial remittance. FIG. 2 is a graph of spatial remittance profiles that were experimentally obtained from aortic atherosclerotic plaques in vitro. Both figures are an experimental fit of shining light in (wavelength is 633 nm) and looking at the light coming out (spatial remittance distribution) using a CCD array. FIG. 2 shows Gaussian fits of the spatial remittance profiles measured from a normal aorta and two lipid-rich plaques, one containing a thick fibrous cap and the other, a thin fibrous cap. The trend towards decreasing remittance distribution width is a result of a decrease in the amount of light scattered from the fibrous cap (λ=633 nm). FIG. 2 shows the light entering at distance=0 and remittance is graphed as a function of distance from where the light went into the cap. The solid line is a normal aorta; the dotted line is thick cap plaque (about 150 micrometers); and the dashed line is thin cap plaque (about 40 micrometers). The concept is that the optical properties are different in the lipid pool than in the cap so when light is incident on a thick cap plaque, the spatial reflectivity profile is primarily affected by the cap optical properties. For thinner caps, the spatial reflectivity is more dependent on the lipid optical properties. In other words, for thick cap plaques, the spatial reflectance profile more closely resembles spatial reflectance from a fibrous layer of semi-infinite thickness, whereas for a thin cap plaque, the spatial reflectance profile more closely resembles the spatial reflectance from a semi-infinite lipid pool. This technique may be enhanced by selecting wavelengths (e.g., 450-500 nm, 1050-1350 nm, and 1600-1850 nm) which are preferentially absorbed by lipid.


There have been prior attempts to measure the optical properties of human atheromas, but these studies suffer from a number of deficiencies and inaccuracies. In addition, the unique optical properties of atherosclerotic caps and lipid pools have not been independently measured.


Table 1 shows the optical properties of the cap and lipid pool (literature and unpublished research) used for Monte Carlo simulations at 633 nm and 476 nm.












TABLE 1







633 nm
476 nm
















CAP










Ma = 3.6 cm−1
Ma = 14.8 cm−1



Ms = 171 cm−1
Ms = 237 cm−1



g = .85
g = .85







LIPID POOL










Ma = 3.6 cm−1
Ma = 45 cm−1



Ms = 870 cm−1
Ms = 1200 cm−1



g = .95
g = .95











FIG. 3 shows the results of a Monte Carlo simulation (a “random walk” technique known to those skilled in the art) of radial remittance (distance in mm) as a function of remittance or reflectance (a.u.). The solid line represents the radial remittance at 476 mm for a thick cap (150 micrometers) and the dashed line is for a thin cap (65 micrometers). The spatially dependent reflectance for the thin cap model is lower than that of the thick cap plaque due to the increased fluence in the lipid pool and resultant increased absorption.


Multiple wavelengths may be used to improve the accuracy of this technique. Spatial reflectance measurements may be obtained for a sufficient number of wavelengths to solve for the multiple degrees of freedom present in the N-layered model. Variables that need to be determined to accurately determine the cap thickness include the absorption coefficient, the transport scattering coefficients for each layer and the layer thickness.


One method according to the present invention for measurement of plaque optical properties and cap thickness is as follows:

  • 1) Perform Monte Carlo simulations varying cap and lipid pool optical properties and cap thicknesses;
  • 2) Develop a lookup table of Monte Carlo results;
  • 3) Perform spatial reflectance distribution measurements for N wavelengths;
  • 4) Fit the measured spatial reflectance distribution to known Monte Carlo simulation results (e.g., by the Levenberg-Marquardt method); and,
  • 5) Output the optical properties and cap thickness from the previously computed Monte Carlo simulation that closely approximates the experimental measurements


    Time Dependence


FIG. 4A(i) shows a graph of a short temporal pulse going in and FIG. 4B shows a graph of the decay and broadening of the pulse coming out, which allows the measurement of the effective attenuation coefficient: μeff=1/[3μssa)] or the total attenuation coefficient, μtsa, where μt is the total scattering coefficient, μa is the absorption coefficient, and μs is the scattering coefficient. FIG. 4B is indicative of a liquid pool where a pulse enters and is broadened by effects of the optical properties of the cap and the lipid pool, causing the decay curve to change. For a two-layered structure, there will be a superposition of two decay curves, one due to the optical properties of the cap, and the other due to the optical properties of the lipid pool. So, in FIG. 4C there are two decay curves, the left most slope “1”, is e−μ1t is due to the cap alone and the right most slope “2”, is e−μ2t is due to the cap plus lipid pool. In this graph μ1t cap and μ2t cap+liquid. Determination of the cutoff region where the exponential decay changes allows for the measurement of cap thickness.



FIGS. 5A and 5B are schematic illustrations of a generalized view of a catheter 10 which comprises a light source 12, a beam splitter 14, a probe 16, a fiber 18, a lens 20 (optional), a reflecting element 22 (which is optional; alternatively, it can go straight through the catheter 10), a detector 24 (such as, but not limited to, a CCD, one dimensional array, two dimensional array, and the like), an optional polarizer 26, rotational coupler 28, and a sample 30. There is a coupler 28 at the proximal end of the catheter device 10 which may rotate or translate the incident beam of light to perform cross-sectional or longitudinal imaging of the vessel optical properties. It is also possible to have an image fiber 32 bundle which can rotate. Also, there optionally can be an irradiant port 34. Optionally, there can be a plurality of lenses 20 or at least one polarizing filter 36 (not shown), depending on which imaging method is to be used.



FIG. 5C shows a schematic of a system 50 having a short pulse source 52, which passes a light beam 54 into the beam splitter 55 (BS), into and back out of the probe 56. The system 50 includes a time gated electronic 58, known to those skilled in the art; for example, but not by way of limitation, a Kerr lens 60, a streak camera, high speed photodiode detector, or the like.



FIGS. 6A and 6B show graphs where instead of putting a pulse of light in, one uses an oscillating light in at amplitude A1 and out at amplitude A2, where a phase shift (φ) occurs between the two peaks in FIGS. 6A and 6B and there is an amplitude decrease where A2<A1.



FIG. 7A shows cap thickness as a function of frequency (F) where two peaks ALP (amplitude of the lipid pool) and ACAP (amplitude of the cap) are related to the optical properties. FIG. 7B shows a phase plot of the angle F as a function of φ in radians and is also dependent on cap thickness and optical properties.



FIG. 8 shows a schematic of an alternative embodiment of a system 70 having a light source 72, a modulator 74, a beam splitter 76, and a probe 78. There is also a demodulator 80, either optical or electronic, and a detector 82.


One can also combine spatial frequency and spatial time and/or modulated phase and amplitude measurements.


Multiple Wavelength Reflectance Measurements


The use of the differential penetration depth of light within the fibrous cap provides a simple method for estimating cap thickness. This technique may be performed using a single point measurement or for multiple points as a spatially dependent reflectance profile (as mentioned above). The principle behind this method is illustrated by the following aspects:

  • 1) λ1 has a lower wavelength and a resultant decreased penetration depth.
  • 2) λ2 has a higher wavelength and a resultant increased penetration depth.
  • 3) Both λ1 and λ2 are absorbed by lipid and predominantly scattered by the cap (see wavelengths discussed above).
  • 4) If the cap is thin, then the reflectance (Iλ1) is higher than 1λ2 and the ratio, R═Iλ1/Iλ2 is high. This is due to the fact that λ1 light is scattered back to the detector before it is absorbed, whereas the λ2 light penetrates the cap and is absorbed.
  • 5) If the cap is thick, then the reflectance (Iλ1) is roughly equal to Iλ2 and the ratio, R=Iλ1/Iλ2≈K2. Also, each individual Iλ1 and Iλ2 are high.
  • 6) If the cap is very thin (i.e., indicating likely vulnerable plaque), then both wavelengths penetrate the cap, the ratio, R=Iλ1/Iλ2≈K1, and each individual Iλ1 and Iλ2 are relatively low.
  • 7) Additional wavelengths and/or spatial reflectance measurements may be used to increase the accuracy of this technique.



FIG. 9 shows Monte Carlo wavelength ratiometric spatial reflectance distributions for two different cap thicknesses. For this simulation, the maximum difference between ratios for the two cap thickness (65 μm and 150 μm) occurs at a source detector separation of d=200 μm. This simulation shows that the sensitivity of this technique may be improved using spatial reflectance measurements (e.g., source and detector locations separated by a distance d).


There are multiple different wavelength ratiometric equations, including, but not limited to:

R=Iλ1/Iλ2  (1)
R=(1−Iλ2)/(1+Iλ2)  (2)
R=Iλ1/(1+Iλ2)  (3)
R=(1−Iλ2)/2  (4)

The appropriateness of the equation depends on whether or not the total reflectance needs to be accounted for (normalized) to correct for intrapatient and interpatient variation of the cap and lipid pool optical properties.


Low Coherence Interferometry


Low coherence interferometric imaging or optical coherence tomography is a non-invasive cross-sectional imaging technique capable of providing high-resolution images of optical backscattering within tissue. OCT is currently being developed as a commercial product and will likely begin wide-scale clinical trials in the coming years. Current OCT systems have a resolution of 10 μm. Although this resolution allows for imaging of tissue architectural morphology, cellular features are not directly resolved by OCT. As a result, quantitative/qualitative algorithms must be used to correlate architectural features visualized by OCT to identify coronary atherosclerotic plaque type.


Interpretation of OCT images is based on several hypotheses that are directly supported by clinical experience:


1. OCT signal strength increases with nuclear (N) density


2. OCT signal strength increases with fibrous tissue density


3. Lipid exhibits a low OCT signal


4. Calcifium may exhibit a low or high (or alternating low and high) OCT signal


5. The refractive indices of fibrous tissue, lipid, and calcium are distinct. As a result, for well-delineated structures, a high OCT signal (Fresnel reflection) may be observed at the interface between different tissue types.


An algorithm for feature extraction from OCT images is described below. Final diagnosis of coronary pathology can be determined using a grading scheme incorporating some or all of the parameters described herein.


Qualitative Features










TABLE 2





Histopathologic Finding
OCT Features







Intimal hyperplasia
Signal-rich layer nearest lumen


Media
Signal-poor middle layer


Adventitia
Signal-rich, heterogeneous outer layer


Internal elastic lamina
Signal-rich band (~20 μm) between



the intima and media


External elastic lamina
Signal-rich band (~20 μm) between



the media and adventitia


Atherosclerotic plaque
Loss of layered appearance, narrowing



of lumen


Fibrous tissue
Homogeneous, signal-rich region


Lipid pool
Heterogeneous, poorly delineated,



signal-poor (echolucent region)


Fibrous cap
Signal-rich band overlying echolucent



region


Macrocalcification
Large, heterogeneous, sharply delin-



eated, signal-poor or signal-rich region


Microcalcification
Punctate high-signal region


Dissections
Intimal/medial defect


Thrombus
Homogeneous, well-defined structure



adherent to luminal



surface protruding into vessel lumen









Table 2 describes the OCT qualitative features corresponding to histologic finding. Table 2 partially overlaps with published data. However, many OCT features described in Table 2 have not been mentioned in the literature.


We have also recently noted two types of lipid pools, homogeneous and heterogeneous. Homogeneous lipid pools have a greatly decreased signal and contain a Fresnel reflection at the interface. Heterogeneous lipid pools have increased signal compared to homogeneous lipid pools and do not have a visible Fresnel reflection.


Quantitative Features


While many cross-sectional OCT images of human coronary arteries can be readily characterized using simple, qualitative features, heterogeneous plaques with complex components are difficult to interpret. In these cases, the appearance of lipid-rich plaques with thin fibrous caps was similar to that of fibrous plaques with calcifications. To date, few investigators have used advanced image processing algorithms for OCT. Preliminary studies suggest that substantial improvements can be made in identifying tissue constituents through systematic analysis of the two-dimensional OCT signal and that algorithms can be developed for applying this information for contrast enhancement and segmentation.


In current OCT systems, the intensity of light returning from discrete locations within the sample comprises the image data set. The signal detected from any one location is determined by both the attenuation incurred along the optical path between the catheter and the location and the actual reflectivity at that location, R(z):

I(z)=I0R(z)custom charactere−μt(z)zdz,  Eq. 1

where I0 is the incident light intensity, μt is the total attenuation coefficient and z is the distance along the optical axis. As light propagates within tissue it is attenuated by scattering and absorption. In a homogeneous medium, the total attenuation coefficient is independent of depth resulting in a single-exponential decay of signal with depth. In more complex structures the spatial dependence of the attenuation coefficient gives rise to an exponential decay curve with locally varying slope.


Recent work in our laboratory has shown that OCT data representing different components of plaques have distinct local intensity distributions. This realization has motivated the use of three methods for quantitative analysis and segmentation of OCT data representing different tissue types. Computation of the histograms or probability distribution functions (PDF) for different tissue regions has shown that each tissue type has a distinct PDF (FIG. 10), making it likely that local PDF statistics such as the mean, standard deviation and skew could be used for image segmentation. Next, preliminary analysis of existing data shows that separate plaque components have different local spatial frequency distributions or textures. Due to the fractal nature of biological tissue, the fractal dimension (D) was chosen as a quantitative measure of local texture in OCT images. FIG. 10B is an OCT image containing a lipid-rich region, a calcification, and a fibrous cap. Following processing, each different plaque component was found to have a distinct fractal dimension (D). FIG. 10C is an OCT be image showing a fibrous cap and a lipid pool with different total attenuation coefficients. FIG. 10D is an OCT image of a large intimal calcification has a higher total attenuation coefficient than either the fibrous cap or lipid pool in FIG. 10C. In FIG. 10B, following local histogram equalization and binary segmentation, the fractal dimension was calculated for each plaque component using the box-counting method. Initial results suggest that the fractal dimensions for lipid-pools, fibrous caps, and calcifications distinguish these tissue types. Finally, as described in Eq. 1, the OCT signal is a function of the tissue reflectance multiplied by a depth-dependent exponential decay. When a logarithm is applied to the OCT signal,

ln [I(z)]=ln [I0]+ln [R(z)]−2μt(z)z  Eq. 2

the exponential decay becomes a change in slope, −2μt(z), which is also known as the depth dependent total attenuation coefficient. In a preliminary study, we have measured μt(z), and have found that it is different for calcifications, fibrous caps, and lipid pools.


The present invention provides an algorithm for calculating μt(z) for each point in the image using adaptive linear regression to create new images that represent corrected total attenuation coefficients and corrected reflection coefficients that will provide improved characterization of tissue constituents. The algorithm is as follows:

  • (1) Identifying of the surface of the tissue at given transverse position, θ0;
  • (2) Selecting a small ROI (e.g., 7×1 pixels) within the radial scan, centered at r0, θ0;
  • (3) Smoothing operation over the ROI (e.g., linear filter);
  • (4) Fitting the slope of the axial reflectivity within the ROI; and,
  • (5) Mapping the slope to total attenuation coefficient and the y-intercept of the slope to corrected reflectivity for r0, θ0 (using more superficial total attenuation coefficients to compensate for the decrease in fluence at the current depth).


    Steps 2-5 are repeated for the entire image.


    Polarization


Polarization sensitive optical coherence tomography is capable of improving the characterization of the composition of atherosclerotic plaques. With this device, quantitative high-resolution depth-resolved detection of plaque birefringence (polarization rotation by the tissue) gives rise to additional information related to plaque composition.



FIG. 11 shows a schematic of a polarization sensitive OCT system 100 according to one embodiment of the present invention. A polarized source (e.g., s state) 102 is incident on a 90/10 beam splitter 104 (BS). Light is directed to the reference arm 106 and sample arm 108 of the interferometers 110 via circulators 112 (C, port 1 to port 2 to port 3), and recombined by a 90/10 beam splitter 114. The s and p states of the recombined light are directed to detectors A and B (116, 118), respectively by a polarizing beam splitter 120 (PBS).


A polarization independent OCT image may be obtained by summing the squares of the magnitude of the interference detected at detectors A and B. If the polarization eigenstates of the electric field incident on the sample are known, then the birefringence of the sample may be computed using a combination of the signals detected by A and B. This is termed polarization sensitive detection. One quantitative measurement of the relative degree of birefringence caused by the sample is:

φ(r,θ)=arctan(A(r,θ)/B(r,θ))  Eq. 3


By analyzing the birefringence, additional information can be obtained from the OCT signal. FIGS. 12A and B show OCT images of human coronary artery plaque acquired in vivo. FIG. 12A is a polarization independent image showing the presence of a fibrous plaque from 11 o'clock to 8 o'clock (clockwise). FIG. 12B is a polarization sensitive image showing presence of bands (arrows) within the fibrous plaque.


In the polarization independent image (FIG. 12 A), the coronary plaque appears as a homogeneous signal-rich region which obliterates the normal layered structure of the artery. FIG. 12B shows the birefringence image (φ(r,θ)) of the same plaque. Radial bands are seen within the lesion, representing rotation of the polarization by the sample through several phases of the arctangent. The existence of these bands suggests that this plaque contains abundant, regularly oriented collagen fibers. A less stable plaque with a decreased collagen content should not show this banding structure.


Collagen content is the major intrinsic factor contributing to the stability of a plaque. As a result, a method for measuring the collagen content and its structural orientation will provide additional diagnostic information for differentiating stable from unstable plaques. Also, since an increase in plaque collagen content has been recognized as one of the most important structural changes that occurs following lipid-lowering therapy, measurement of the collagen content with this technique could enable monitoring of plaque regression after pharmacological therapy. In addition, the polarization sensitive OCT signal may improve the capability of OCT to differentiate lipid from fibrous tissue and fibrous tissue from calcium. Finally, other constituents commonly found in atherosclerotic plaques, such as cholesterol crystals, may have a unique polarization sensitive OCT signal.



FIGS. 13A-C show images taken using polarization sensitive OCT. FIG. 13A is an OCT polarization diversity image; FIG. 13B is a polarization sensitive image; and, FIG. 13C is the histology of the same site. There is a difference between the polarization birefringence for lipid and adjacent collagen. In the polarization sensitive image one can see that there is banding which means rotation of the polarization state (indicated by the arrow). In addition the lipid pool randomly alters the polarization state showing a very homogeneous speckle pattern in FIG. 13B. The fibrous tissue shows a banding pattern. Experimental results have also shown that calcifications, which at times may be very difficult to distinguish from lipid, do not have random alterations in returned polarization and are also not birefringent.


Macrophage Measurement


Example 1 discussed hereinbelow provides a method and an algorithm for identifying macrophages in fibrous caps.


EXAMPLES
Example 1

This example was a project to explore the potential of OCT for identifying macrophages in fibrous caps of atherosclerotic plaques.


Specimens


264 grossly atherosclerotic arterial segments (165 aortas, 99 carotid bulbs) were obtained from 59 patients (32 male and 27 female, mean age 74.2±13.4 years) at autopsy and examined. 71 of these patients had a medical history of symptomatic cardiovascular disease (27.1%). The harvested arteries were stored immediately in phosphate buffered saline at 4 C.°. The time between death and OCT imaging did not exceed 72 hours.


OCT Imaging Studies


The OCT system used in this Example has been previously described. OCT images were acquired at 4 frames per second (500 angular pixels×250 radial pixels), displayed with an inverse gray-scale lookup table, and digitally archived. The optical source used in this experiment had a center wavelength of 1310 nm and a bandwidth of 70 nm, providing an axial resolution of approximately 10 μm in tissue. The transverse resolution, determined by the spot size of the sample arm beam, was 25 μm.


Before OCT imaging, arteries were warmed to 37° C. in phosphate buffered saline. Each carotid bulb and aorta was opened and imaged with the luminal surface exposed. The position of the interrogating beam on the tissue was monitored by a visible light aiming beam (laser diode, 635 nm) that was coincident with the infrared beam. Precise registration of OCT and histology was accomplished by applying ink marks (Triangle Biomedical Sciences, Durham, N.C.) to the vessels at the imaging site, such that each OCT image and corresponding histologic section contained visually recognizable reference points.


Staining


After imaging, the tissue was processed in a routine fashion. Arterial segments were fixed in 10% Formalin (Fisher Scientific, Fair Lawn, N.J.) for at least 48 hours. Arteries with substantial calcification were decalcified (Cal-EX, Fisher Scientific) prior to standard paraffin embedding. Four-micron sections were cut at the marked imaging sites and stained with hematoxylin and eosin (H&E) and Masson's trichrome. To visualize the presence of macrophages and smooth muscle cells, a mouse-antihuman CD68 monoclonal antibody and alpha-actin monoclonal antibody (Dako Corporation, Carpinteria, USA) were used, respectively. Immunohistochemical detection of the preferred epitopes was performed according to the indirect horseradish peroxidase technique. After blocking with horse serum, the tissue was incubated with primary antibodies followed by horse anti-mouse secondary antibody and streptavidin with peroxidase (BioGenex) for anti-smooth muscle actin or avidin-biotin horseradish peroxidase complex (Dako) for anti-CD68. Slides were developed with 3-amino-9-ethyl-carbazole (Sigma) and counterstained with Gill's hematoxylin (Fisher Scientific). All slides were digitized for histomorphometric analysis (Insight Camera, Diagnostic Instruments, Sterling Heights, Mich.).


Correlation between OCT Images and Histopathology


264 OCT images and correlating histologic sections were obtained using the ink marks as points of reference. From this set, 26 plaques identified as fibroatheromas by histology with precise registration between OCT and histology as determined by reference ink marks and minimal superficial calcification by histology, were selected to correlate measurements of macrophage density.


Morphometric Analysis


Using both digitized histology and OCT, measurements of macrophage density were obtained using a 500×125 μm (lateral×axial) region of interest (ROI), located in the center of the plaque (FIG. 1). For caps having a thickness less than 125 μm, the depth of the ROI was matched to the cap thickness.


OCT measures the intensity of light returning from within a sample. Samples having a higher heterogeneity of optical index of refraction exhibit stronger optical scattering and therefore a stronger OCT signal. If the characteristic size scale of the index of refraction heterogeneity is larger than the resolution, then the OCT signal will have a larger variance. Previous research conducted to measure the optical properties of human tissue has shown that the refractive index of lipid and collagen is significantly different. These results suggest that caps containing macrophages should have multiple strong backreflections, resulting in a relatively high OCT signal variance. Using standard image processing methods, the variance, σ2, within the ROI of an OCT image can be represented by:











σ
2

=


1

N
-
1






ROIwidth








ROIheight







(


S


(

x
,
y

)


-

S
_


)

2





,




Eq
.




4








where N is the number of pixels in the ROI, ROIwidth is the width of the ROI, ROIheight is the height of the ROI, S(x,y) is the OCT signal as a function of x and y locations within the ROI, and S is the average OCT signal within the ROI.


OCT images contain tissue backreflection information that span a large dynamic range (100 dB or 10 orders of magnitude). The dynamic range of OCT is too high to be displayed on a standard monitor that may have a dynamic range of only 2-3 orders of magnitude. As a result, the signal range of most OCT images are compressed by taking the base 10 logarithm of the OCT image prior to display. While taking the logarithm of the OCT image data enables convenient image display, compression of the data range in this manner diminishes image contrast. In this study, we investigated the capabilities of both the raw (linear) OCT data and the logarithm of the OCT data for quantifying macrophage content within fibrous caps.


Prior to computing the image standard deviation, the OCT data within the ROI was preprocessed using the following steps: 1) the mean background noise level was subtracted, and 2) median filtering using a 3×3 square kernel was performed in order to remove speckle noise (IPLab Spectrum 3.1, Scanalytics, Vienna, Va.). Following preprocessing, or within the ROI was calculated and tabulated for each specimen. In order to correct the data for variations in OCT system settings, σ was normalized by the maximum and minimum OCT signal present in the OCT image:











N





S





D

=

σ

(


S
max

-

S
min


)



,




Eq
.




5








where NSD is the normalized standard deviation of the OCT signal, Smax is the maximum OCT image value, and Smin is the minimum OCT image value.


The area percentage of CD68+ and smooth muscle actin staining was quantified (at 100× magnification) using automatic bimodal color segmentation within the corresponding ROI's of the digitized Immunohistochemical stained slides (IPLab Spectrum 3.1, Scanalytics, Vienna, Va.). The NSD within each cap was then compared with immunohistochemical staining from slides obtained from corresponding locations.


Statistics


OCT measurements of macrophage and smooth muscle density were compared to histologic measurements using linear regression. In addition, following retrospective application of an NSD threshold, the accuracy of OCT for identifying caps with >10% CD68+ staining was determined. All continuous variables are expressed as mean±standard deviation. A p value <0.05 was considered statistically significant.


Results


Macrophage Density


The OCT signal within the cap is relatively homogeneous for low macrophage density, whereas for high macrophage content, the OCT image of the cap is heterogeneous with punctate, highly reflecting regions. The relationship between macrophage density determined by immunohistochemistry and the NSD measured by OCT is depicted in FIG. 14 for both the raw and base 10 logarithm OCT data. For the raw OCT data, a correlation of r=0.84 (p<0.0001) was found between OCT NSD and CD68+% staining, whereas for the base 10 logarithm OCT data, a correlation of r=0.47 (p<0.05) was found between OCT NSD and CD68+% staining.


Morphometric evaluation of 26 slides stained with CD68 showed 9 caps with a CD68+ area greater than 10% and 17 caps with a CD68+ area less than 10%. Receiver operating characteristic (ROC) curves for the raw and base 10 logarithm OCT signal NSD's are depicted in FIG. 4. For the raw OCT signal NSD, a range of NSD's (6.15%-6.35%) demonstrated 100% sensitivity and specificity (□ value 1.0) for differentiating caps containing >10% CD68+ staining. For the base 10 logarithm OCT signal, NSD values ranging from 7.65%-7.75% provided 70% sensitivity and 75% specificity (□ value 0.44) for identifying caps containing >10% CD68+ staining. A comparison of the OCT NSD and CD68+ staining is summarized in Table 3. CD 68+% staining cutoff 10%. Data in parenthesis represents 95% confidence interval. OCT—Optical Coherence Tomography; NSD—Normalized Standard Deviation of OCT signal.












TABLE 3







Raw OCT Signal
Logarithm OCT signal




















Correlation (r)
0.84
(p < 0.0001)
0.47
(p < 0.05)









NSD Cutoff
6.2%
7.7%











Sensitivity
1.0
(0.69-1.0)
0.70
(0.35-0.93)


Specificity
1.0
(0.8-1.0)
0.75
(0.48-0.93)


Positive Predictive Value
1.0
(0.69-1.0)
0.64
(0.3-0.89)


Negative Predictive Value
1.0
(0.8-1.0)
0.80
(0.52-0.96)










Smooth Muscle Cell Density


A negative correlation was found between CD68 and smooth muscle actin % area staining (r=−0.44, p<0.05). In turn, a statistically significant negative relationship between smooth muscle cell density determined by immunohistochemistry and OCT NSD was observed for both the raw and base 10 logarithm OCT data. For the raw OCT data, a correlation of r=−0.56 (p<0.005) was found between OCT NSD and smooth muscle actin+% staining, whereas for the base 10 logarithm OCT data, a correlation of r=−0.32 (p=0.12) was found between OCT NSD and smooth muscle actin+% staining.


Other Findings


Macrophages at the cap-lipid pool interface: CD68 staining demonstrated a significant accumulation of macrophages at the cap-lipid pool interface in (n=19) cases. In 16 of these cases (84%), a higher OCT signal was also present at the junction between the cap and the lipid pool, confirming that the increase in OCT signal was in part due to increased backreflection by macrophages at the cap-lipid pool interface. For the three CD68+ cases lacking an increase in OCT signal at the junction, either the cap was greater than 300 μm in thickness or the entire cap was infiltrated by macrophages. In the three cases that were negative for CD68 at the cap-lipid pool interface, an increased OCT interface signal corresponded to cholesterol crystals present at the junction.


Although many new approaches under investigation for plaque characterization show great promise, none provide direct evidence of macrophage presence. This Example demonstrates that OCT is capable of visualizing macrophages and quantifying cap macrophage content. Since the OCT signal increases with the number of refractive index mismatches in tissue, caps containing macrophages should have multiple strong backreflections. A simple computational analysis of ROI's within OCT images of fibrous caps (NSD) was developed to test this hypothesis. When validated against immunohistochemistry, this parameter demonstrated a high degree of correlation with CD68 staining at corresponding locations (r=0.84 for raw OCT data NSD).


While little is known about the precise relationship between cap macrophage density and plaque vulnerability, studies have shown that plaques with a macrophage content in the range of 10%-20% are more likely to be associated with unstable angina and non-Q wave myocardial infarction6. As a result, we selected 10% CD68+ area as a cutoff for high macrophage content. Using the ROC to select an appropriate NSD threshold, we found that OCT was capable of accurately distinguishing fibrous caps with low macrophage content from fibrous caps with high macrophage content (100% sensitivity and specificity for raw OCT data NSD).


An increased number of smooth muscle cells have been observed within plaques in patients who have unstable angina and within erosive plaques implicated in a subset of acute myocardial infarctions. In this work, we found an inverse correlation between CD68 and smooth muscle actin staining from corresponding locations within plaque caps (r=−0.44, p<0.05). The negative correlation between the raw OCT data NSD and smooth muscle actin staining (r=−0.56, p<0.005) may in part reflect the inverse relationship between macrophages and smooth muscle cells in our data. Nevertheless, it appears that the OCT NSD is specific for macrophage content, as opposed to being a more general metric of increased cellular density.


In this Example, both the raw OCT signal and the logarithm of the OCT signal was processed and compared with CD68 immunohistochemical positivity. While the logarithm of the OCT signal provides an increased dynamic range for image display, it also apparently decreases the contrast between macrophages and surrounding matrix (Table 3).


Alternative Methods for Identifying Inflammation in Atherosclerotic Plaques


Diffuse near-infrared (NIR) reflectance spectroscopy is a quantitative approach that utilizes the spectrum of light scattered from within the vessel wall. A recent study, performed on cadaver specimens, has demonstrated that chemometric analysis of the NIR spectrum may allow identification of plaques containing abundant inflammatory cells. Based on the hypothesis that local inflammation within vulnerable plaques may lead to local elevations in temperature, studies have recently been performed using a temperature-sensing catheter. Experiments performed in patients have indicated that both temperature heterogeneity and the temperature difference between atherosclerotic plaque and healthy vessel walls increase with disease severity. Both NIR spectroscopy and thermography appear quite promising for assessing inflammation within plaques, but these diagnostic techniques are not specific for macrophages and may need to be combined with another imaging modality to precisely determine whether or not the inflammatory cells are confined to the fibrous cap, or are present throughout the plaque. Recently, ultrasmall superparamagnetic particles of iron oxide (USPIOs) have been proposed for delineation of inflammatory changes accompanying atherosclerotic disease. The limited resolution of MRI, however, renders the localization of macrophages within thin fibrous cap and plaque shoulders difficult.


Alternative Algorithms and Methods:


In addition to the algorithm described hereinabove in Example 1, the following alternative embodiments for determining macrophage content could also be employed:


Any combination of the techniques described below could be used in an algorithm for determining macrophage density


Focus Tracking


Precise knowledge of the position of the focus of the imaging lens may be needed for accurate quantification. This may be accomplished by determining the maximum axial OCT signal or by a priori knowledge of the position of the focus on the OCT image.


Correction of Focus


The OCT image may be corrected to form a map of the true backscattering coefficient by an adaptive correction for the attenuation coefficient and extrapolation using 1×n kernels in the OCT image. The resultant image would be a map of the true backscattering coefficients, corrected for attenuation.


Intensity Normalization




  • 1. Calibration of the OCT system prior to imaging using a known reflectance standard. Alternatively, the normalization may occur within the image where the region of interest for macrophage density determination is normalized to an adjacent region with homogeneous backscattering, presumably representing acellular fibrous tissue.

  • 2. ROI's and/or Images are normalized by the calibration data so that the backscattering coefficient data is absolute.


    Computation of Macrophage Density within ROI
    • (1) Global ROI mean, variance, standard deviation, skew
    • (2) Fourier transform high frequency energy
    • (3) Local variance, standard deviation
    • (4) Segmentation and blob number or area counting
    • (5) Edge density
    • (6) Spatial gray level co-occurrence matrix parameters
    • (7) Fractal dimension
    • (8) Run-length measurements


      Cluster Analysis or Threshold Application



Cluster analysis or threshold application may be needed to separate out plaques or ROI's with high macrophage content versus low macrophage content.


It will be understood that the terms “a” and “an” as used herein are not intended to mean only “one,” but may also mean a number greater than “one.” All patents, applications and publications referred to herein are hereby incorporated by reference in their entirety. While the invention has been described in connection with certain embodiments, it is not intended to limit the scope of the invention to the particular forms set forth, but, on the contrary, it is intended to cover such alternatives, modifications, and equivalents as may be included within the true spirit and scope of the invention as defined by the appended claims.

Claims
  • 1. An apparatus for obtaining information associated with at least one plaque structure, comprising: at least one arrangement which is configured to receive at least one first electromagnetic radiation at a first wavelength and at least one second electromagnetic radiation at a second wavelength from the at least one plaque structure, wherein the at least one arrangement determines the information as a function of the first and second electromagnetic radiations,wherein a first one of the at least one first electromagnetic radiation is at least partially returned from a first depth of at least one anatomical structure, wherein a second one of the at least one first electromagnetic radiation is at least partially returned from a second depth of the at least one anatomical structure, wherein the first depth is different from the second depth, and wherein the at least one arrangement is configured to determine data associated with a spatial location of the anatomical structure within a sample based on a combination of the first and second ones of the at least one first electromagnetic radiation.
  • 2. The apparatus according to claim 1, wherein the information comprises at least one characteristic associated with the at least one plaque structure.
  • 3. The apparatus according to claim 1, wherein the at least one plaque structure is at least one anatomical structure.
  • 4. The apparatus, according to claim 1, wherein the at least one arrangement is configured to generate data that is usable for producing at least one image of the at least one anatomical structure based on the information.
  • 5. The apparatus according to claim 1, wherein the first and second ones of the at least one first electromagnetic radiations are image signals.
  • 6. An apparatus for obtaining information associated with at least one plaque structure, comprising: at least one arrangement which is configured to receive at least one first electromagnetic radiation at least one first location returned from that at least one plaque structure which is associated with at least one second electromagnetic radiation illuminating a predetermined distinct portion of at least one plaque structure at a second predetermined location, wherein the first and second locations are different from one another, and wherein the at least one arrangement determines the information as a function of a combination of the first and second electromagnetic radiations,wherein the information comprises at least one characteristic associated with the at least one plaque structure, and wherein the at least one characteristic includes at least one optical property of the plaque structure.
  • 7. The apparatus according to claim 6, wherein the at least one characteristic includes a presence of at least one lipid-containing structure.
  • 8. The apparatus according to claim 6, wherein the at least one characteristic includes at least one of a presence, a thickness, a spatial distribution or a composition of at least one cap.
  • 9. The apparatus according to claim 6, wherein the at least one characteristic includes at least one of a presence, a quantity, a type or a spatial distribution of at least one collagen.
  • 10. The apparatus according to claim 6, wherein the at least one characteristic includes at least one of a presence, a quantity, a type or a spatial distribution of at least one smooth muscle cell.
  • 11. The apparatus according to claim 6, wherein the at least one characteristic includes at least one of a presence, a quantity, a type or a spatial distribution of at least one of (i) intima, (ii) intimal hyperplasia, (iii) media, (iv) adventitia, (v) internal elastic lamina, (vi) external elastic lamina, (vii) calcification, (viii) dissection, (ix) thrombus, or (x) erosion.
  • 12. The apparatus according to claim 6, wherein the at least one second electromagnetic radiation includes at least two radiations which are received to two separate locations.
  • 13. The apparatus according to claim 6, wherein the at least one arrangement generates data which is usable for providing at least one image of the at least one plaque structure at the at least one first location.
  • 14. A method for obtaining information associated with at least one anatomical structure, comprising: receiving at least one first electromagnetic radiation at a first wavelength and at least one second electromagnetic radiation at a second wavelength from the anatomic structure; andusing a system to determine the information as a function of the first and second electromagnetic radiations, wherein a first one of the at least one first electromagnetic radiation is at least partially returned from a first depth of at least one anatomical structure, wherein a second one of the at least one first electromagnetic radiation is at least partially returned from a second depth of the at least one anatomical structure, and wherein the first depth is different from the second depth; anddetermining data associated with a spatial location of the anatomical structure within a sample based on a combination of the first and second ones of the at least one first electromagnetic radiation.
  • 15. A method for obtaining information associated with at least one plaque structure, comprising: receiving at least one first electromagnetic radiation at least one first location returned from that at least one plaque structure which is associated with at least one second electromagnetic radiation illuminating a predetermined distinct portion of at least one plaque structure at a second predetermined location, wherein the first and second locations are different from one another; andusing a system to determine the information as a function of a combination of the first and second electromagnetic radiations electromagnetic radiation, wherein the information comprises at least one characteristic associated with the at least one plaque structure, and wherein the at least one characteristic includes at least one optical property of the plaque structure.
  • 16. The method according to claim 15, wherein the at least one optical property is a property associated with at least one of (i) a scattering coefficient, (ii) an absorption coefficient, (iii) an effective attenuation coefficient, or (iv) a total attenuation coefficient.
  • 17. The apparatus according to claim 6, wherein the at least one optical property is a property associated with at least one of (i) a scattering coefficient, (ii) an absorption coefficient, (iii) an effective attenuation coefficient, or (iv) a total attenuation coefficient.
  • 18. An apparatus for obtaining information associated with at least one plaque structure, comprising: at least one arrangement which is configured to receive at least one first electromagnetic radiation at least one first location returned from that at least one plaque structure which is associated with at least one second electromagnetic radiation illuminating a predetermined distinct portion of at least one plaque structure at a second predetermined location, wherein the first and second locations are different from one another, and wherein the at least one arrangement determines the information as a function of the at least one first electromagnetic radiation,wherein a first one of the at least one first electromagnetic radiation is at least partially returned from a first depth of at least one anatomical structure, wherein a second one of the at least one first electromagnetic radiation is at least partially returned from a second depth of the at least one anatomical structure, wherein the first depth is different from the second depth, and wherein the at least one arrangement is configured to determine data associated with a spatial location of the anatomical structure within a sample based on a combination of the first and second ones of the at least one first electromagnetic radiation.
  • 19. A method for obtaining information associated with at least one plaque structure, comprising: receiving at least one first electromagnetic radiation at least one first location returned from that at least one plaque structure which is associated with at least one second electromagnetic radiation illuminating a predetermined distinct portion of at least one plaque structure at a second predetermined location, wherein the first and second locations are different from one another; andusing a system to determine the information as a function of the at least one first electromagnetic radiation,wherein a first one of the at least one first electromagnetic radiation is at least partially returned from a first depth of at least one anatomical structure, wherein a second one of the at least one first electromagnetic radiation is at least partially returned from a second depth of the at least one anatomical structure, wherein the first depth is different from the second depth, and wherein the at least one arrangement is configured to determine data associated with a spatial location of the anatomical structure within a sample based on a combination of the first and second ones of the at least one first electromagnetic radiation.
CROSS-REFERENCE TO RELATED APPLICATION(S)

The present application is a divisional of U.S. patent application Ser. No. 10/137,749, filed May 1, 2002 now U.S. Pat. No. 7,865,231. This application also claims priority from provisional application No. 60/287,899, filed May 1, 2001, and commonly assigned to the assignee of the present application. The disclosures of these applications are incorporated herein by reference in their entireties.

US Referenced Citations (476)
Number Name Date Kind
2339754 Brace Jan 1944 A
3090753 Matuszak et al. May 1963 A
3601480 Randall Aug 1971 A
3856000 Chikama Dec 1974 A
3872407 Hughes Mar 1975 A
3941121 Olinger Mar 1976 A
3973219 Tang et al. Aug 1976 A
3983507 Tang et al. Sep 1976 A
4030827 Delhaye et al. Jun 1977 A
4030831 Gowrinathan Jun 1977 A
4140364 Yamashita et al. Feb 1979 A
4141362 Wurster Feb 1979 A
4224929 Furihata Sep 1980 A
4295738 Meltz et al. Oct 1981 A
4300816 Snitzer et al. Nov 1981 A
4303300 Pressiat et al. Dec 1981 A
4428643 Kay Jan 1984 A
4479499 Alfano Oct 1984 A
4533247 Epworth Aug 1985 A
4585349 Gross et al. Apr 1986 A
4601036 Faxvog et al. Jul 1986 A
4607622 Fritch et al. Aug 1986 A
4631498 Cutler Dec 1986 A
4639999 Daniele Feb 1987 A
4650327 Ogi Mar 1987 A
4734578 Horikawa Mar 1988 A
4744656 Moran et al. May 1988 A
4751706 Rohde et al. Jun 1988 A
4763977 Kawasaki et al. Aug 1988 A
4770492 Levin et al. Sep 1988 A
4827907 Tashiro et al. May 1989 A
4834111 Khanna et al. May 1989 A
4868834 Fox et al. Sep 1989 A
4890901 Cross, Jr. Jan 1990 A
4892406 Waters Jan 1990 A
4905169 Buican et al. Feb 1990 A
4909631 Tan et al. Mar 1990 A
4925302 Cutler May 1990 A
4928005 Lefèvre et al. May 1990 A
4940328 Hartman Jul 1990 A
4965441 Picard Oct 1990 A
4965599 Roddy et al. Oct 1990 A
4966589 Kaufman Oct 1990 A
4984888 Tobias et al. Jan 1991 A
4993834 Carlhoff et al. Feb 1991 A
4998972 Chin et al. Mar 1991 A
5039193 Snow et al. Aug 1991 A
5040889 Keane Aug 1991 A
5045936 Lobb et al. Sep 1991 A
5046501 Crilly Sep 1991 A
5065331 Vachon et al. Nov 1991 A
5085496 Yoshida et al. Feb 1992 A
5120953 Harris Jun 1992 A
5121983 Lee Jun 1992 A
5127730 Brelje et al. Jul 1992 A
5197470 Helfer et al. Mar 1993 A
5202745 Sorin et al. Apr 1993 A
5202931 Bacus et al. Apr 1993 A
5208651 Buican May 1993 A
5212667 Tomlinson et al. May 1993 A
5214538 Lobb May 1993 A
5217456 Narciso, Jr. Jun 1993 A
5228001 Birge et al. Jul 1993 A
5241364 Kimura et al. Aug 1993 A
5248876 Kerstens et al. Sep 1993 A
5250186 Dollinger et al. Oct 1993 A
5251009 Bruno Oct 1993 A
5262644 Maguire Nov 1993 A
5275594 Baker Jan 1994 A
5281811 Lewis Jan 1994 A
5283795 Fink Feb 1994 A
5291885 Taniji et al. Mar 1994 A
5293872 Alfano et al. Mar 1994 A
5293873 Fang Mar 1994 A
5302025 Kleinerman Apr 1994 A
5304173 Kittrell et al. Apr 1994 A
5304810 Amos Apr 1994 A
5305759 Kaneko et al. Apr 1994 A
5317389 Hochberg et al. May 1994 A
5318024 Kittrell et al. Jun 1994 A
5321501 Swanson et al. Jun 1994 A
5348003 Caro Sep 1994 A
5353790 Jacques et al. Oct 1994 A
5383467 Auer et al. Jan 1995 A
5394235 Takeuchi et al. Feb 1995 A
5404415 Mori et al. Apr 1995 A
5411016 Kume et al. May 1995 A
5419323 Kittrell et al. May 1995 A
5424827 Horwitz et al. Jun 1995 A
5439000 Gunderson et al. Aug 1995 A
5441053 Lodder et al. Aug 1995 A
5450203 Penkethman Sep 1995 A
5454807 Lennox et al. Oct 1995 A
5459325 Hueton et al. Oct 1995 A
5459570 Swanson et al. Oct 1995 A
5465147 Swanson Nov 1995 A
5486701 Norton et al. Jan 1996 A
5491524 Hellmuth et al. Feb 1996 A
5491552 Kittrell Feb 1996 A
5522004 Djupsjobacka et al. May 1996 A
5526338 Hasman et al. Jun 1996 A
5555087 Miyagawa et al. Sep 1996 A
5562100 Kittrell et al. Oct 1996 A
5565983 Barnard et al. Oct 1996 A
5565986 Knüttel Oct 1996 A
5566267 Neuberger Oct 1996 A
5583342 Ichie Dec 1996 A
5590660 MacAulay et al. Jan 1997 A
5600486 Gal et al. Feb 1997 A
5601087 Gunderson et al. Feb 1997 A
5621830 Lucey et al. Apr 1997 A
5623336 Raab et al. Apr 1997 A
5635830 Itoh Jun 1997 A
5649924 Everett et al. Jul 1997 A
5697373 Richards-Kortum et al. Dec 1997 A
5698397 Zarling et al. Dec 1997 A
5710630 Essenpreis et al. Jan 1998 A
5716324 Toida Feb 1998 A
5719399 Alfano et al. Feb 1998 A
5730731 Mollenauer et al. Mar 1998 A
5735276 Lemelson Apr 1998 A
5740808 Panescu et al. Apr 1998 A
5748318 Maris et al. May 1998 A
5748598 Swanson et al. May 1998 A
5752518 McGee et al. May 1998 A
5784352 Swanson et al. Jul 1998 A
5785651 Kuhn et al. Jul 1998 A
5795295 Hellmuth et al. Aug 1998 A
5801826 Williams Sep 1998 A
5801831 Sargoytchev et al. Sep 1998 A
5803082 Stapleton et al. Sep 1998 A
5807261 Benaron et al. Sep 1998 A
5810719 Toida Sep 1998 A
5817144 Gregory Oct 1998 A
5836877 Zavislan et al. Nov 1998 A
5840023 Oraevsky et al. Nov 1998 A
5840075 Mueller et al. Nov 1998 A
5842995 Mahadevan-Jansen et al. Dec 1998 A
5843000 Nishioka et al. Dec 1998 A
5843052 Benja-Athon Dec 1998 A
5847827 Fercher Dec 1998 A
5862273 Pelletier Jan 1999 A
5865754 Sevick-Muraca et al. Feb 1999 A
5867268 Gelikonov et al. Feb 1999 A
5871449 Brown Feb 1999 A
5872879 Hamm Feb 1999 A
5877856 Fercher Mar 1999 A
5887009 Mandella et al. Mar 1999 A
5892583 Li Apr 1999 A
5910839 Erskine et al. Jun 1999 A
5912764 Togino Jun 1999 A
5920373 Bille Jul 1999 A
5920390 Farahi et al. Jul 1999 A
5921926 Rolland et al. Jul 1999 A
5926592 Harris et al. Jul 1999 A
5949929 Hamm Sep 1999 A
5951482 Winston et al. Sep 1999 A
5955737 Hallidy et al. Sep 1999 A
5956355 Swanson et al. Sep 1999 A
5968064 Selmon et al. Oct 1999 A
5975697 Podoleanu et al. Nov 1999 A
5983125 Alfano et al. Nov 1999 A
5987346 Benaron et al. Nov 1999 A
5991697 Nelson et al. Nov 1999 A
5994690 Kulkarni et al. Nov 1999 A
5995223 Power Nov 1999 A
6002480 Izatt et al. Dec 1999 A
6004314 Wei et al. Dec 1999 A
6006128 Izatt et al. Dec 1999 A
6007996 McNamara et al. Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6014214 Li Jan 2000 A
6016197 Krivoshlykov Jan 2000 A
6020963 Dimarzio et al. Feb 2000 A
6025956 Nagano et al. Feb 2000 A
6033721 Nassuphis Mar 2000 A
6037579 Chan et al. Mar 2000 A
6044288 Wake et al. Mar 2000 A
6045511 Ott et al. Apr 2000 A
6048742 Weyburne et al. Apr 2000 A
6053613 Wei et al. Apr 2000 A
6069698 Ozawa et al. May 2000 A
6078047 Mittleman et al. Jun 2000 A
6091496 Hill Jul 2000 A
6091984 Perelman et al. Jul 2000 A
6094274 Yokoi Jul 2000 A
6107048 Goldenring et al. Aug 2000 A
6111645 Tearney et al. Aug 2000 A
6117128 Gregory Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6134003 Tearney et al. Oct 2000 A
6134010 Zavislan Oct 2000 A
6134033 Bergano et al. Oct 2000 A
6141577 Rolland et al. Oct 2000 A
6151522 Alfano et al. Nov 2000 A
6159445 Klaveness et al. Dec 2000 A
6160826 Swanson et al. Dec 2000 A
6161031 Hochmann et al. Dec 2000 A
6166373 Mao Dec 2000 A
6174291 McMahon et al. Jan 2001 B1
6175669 Colston et al. Jan 2001 B1
6185271 Kinsinger Feb 2001 B1
6191862 Swanson et al. Feb 2001 B1
6193676 Winston et al. Feb 2001 B1
6198956 Dunne Mar 2001 B1
6201989 Whitehead et al. Mar 2001 B1
6208415 De Boer et al. Mar 2001 B1
6208887 Clarke Mar 2001 B1
6245026 Campbell et al. Jun 2001 B1
6249349 Lauer Jun 2001 B1
6249381 Suganuma Jun 2001 B1
6249630 Stock et al. Jun 2001 B1
6263234 Engelhardt et al. Jul 2001 B1
6264610 Zhu Jul 2001 B1
6272376 Marcu et al. Aug 2001 B1
6274871 Dukor et al. Aug 2001 B1
6282011 Tearney et al. Aug 2001 B1
6297018 French et al. Oct 2001 B1
6301048 Cao et al. Oct 2001 B1
6308092 Hoyns Oct 2001 B1
6324419 Guzelsu et al. Nov 2001 B1
6341036 Tearney et al. Jan 2002 B1
6353693 Kano et al. Mar 2002 B1
6359692 Groot Mar 2002 B1
6374128 Toida et al. Apr 2002 B1
6377349 Fercher Apr 2002 B1
6384915 Everett et al. May 2002 B1
6393312 Hoyns May 2002 B1
6394964 Sievert, Jr. et al. May 2002 B1
6396941 Bacus et al. May 2002 B1
6421164 Tearney et al. Jul 2002 B2
6437867 Zeylikovich et al. Aug 2002 B2
6441892 Xiao et al. Aug 2002 B2
6441959 Yang et al. Aug 2002 B1
6445485 Frigo et al. Sep 2002 B1
6445939 Swanson et al. Sep 2002 B1
6445944 Ostrovsky Sep 2002 B1
6459487 Chen et al. Oct 2002 B1
6463313 Winston et al. Oct 2002 B1
6469846 Ebizuka et al. Oct 2002 B2
6475159 Casscells et al. Nov 2002 B1
6475210 Phelps et al. Nov 2002 B1
6477403 Eguchi et al. Nov 2002 B1
6485413 Boppart et al. Nov 2002 B1
6485482 Belef Nov 2002 B1
6501551 Tearney et al. Dec 2002 B1
6501878 Hughes et al. Dec 2002 B2
6516014 Sellin et al. Feb 2003 B1
6517532 Altshuler et al. Feb 2003 B1
6538817 Farmer et al. Mar 2003 B1
6540391 Lanzetta et al. Apr 2003 B2
6549801 Chen et al. Apr 2003 B1
6552796 Magnin et al. Apr 2003 B2
6556305 Aziz et al. Apr 2003 B1
6556853 Cabib et al. Apr 2003 B1
6558324 Von Behren et al. May 2003 B1
6564087 Pitris et al. May 2003 B1
6564089 Izatt et al. May 2003 B2
6567585 Harris May 2003 B2
6593101 Richards-Kortum et al. Jul 2003 B2
6611833 Johnson et al. Aug 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6622732 Constantz Sep 2003 B2
6654127 Everett et al. Nov 2003 B2
6657730 Pfau et al. Dec 2003 B2
6658278 Gruhl Dec 2003 B2
6680780 Fee Jan 2004 B1
6685885 Nolte et al. Feb 2004 B2
6687007 Meigs Feb 2004 B1
6687010 Horii et al. Feb 2004 B1
6687036 Riza Feb 2004 B2
6692430 Adler Feb 2004 B2
6701181 Tang et al. Mar 2004 B2
6721094 Sinclair et al. Apr 2004 B1
6738144 Dogariu et al. May 2004 B1
6741355 Drabarek May 2004 B2
6757467 Rogers Jun 2004 B1
6790175 Furusawa et al. Sep 2004 B1
6806963 Wälti et al. Oct 2004 B1
6816743 Moreno et al. Nov 2004 B2
6831781 Tearney et al. Dec 2004 B2
6839496 Mills et al. Jan 2005 B1
6882432 Deck Apr 2005 B2
6900899 Nevis May 2005 B2
6903820 Wang Jun 2005 B2
6909105 Heintzmann et al. Jun 2005 B1
6949072 Furnish et al. Sep 2005 B2
6961123 Wang et al. Nov 2005 B1
6980299 de Boer Dec 2005 B1
6996549 Zhang et al. Feb 2006 B2
7006231 Ostrovsky et al. Feb 2006 B2
7006232 Rollins et al. Feb 2006 B2
7019838 Izatt et al. Mar 2006 B2
7027633 Foran et al. Apr 2006 B2
7061622 Rollins et al. Jun 2006 B2
7072047 Westphal et al. Jul 2006 B2
7075658 Izatt et al. Jul 2006 B2
7099358 Chong et al. Aug 2006 B1
7113288 Fercher Sep 2006 B2
7113625 Watson et al. Sep 2006 B2
7130320 Tobiason et al. Oct 2006 B2
7139598 Hull et al. Nov 2006 B2
7142835 Paulus Nov 2006 B2
7148970 De Boer Dec 2006 B2
7177027 Hirasawa et al. Feb 2007 B2
7190464 Alphonse Mar 2007 B2
7230708 Lapotko et al. Jun 2007 B2
7231243 Tearney et al. Jun 2007 B2
7236637 Sirohey et al. Jun 2007 B2
7242480 Alphonse Jul 2007 B2
7267494 Deng et al. Sep 2007 B2
7272252 De La Torre-Bueno et al. Sep 2007 B2
7304798 Izumi et al. Dec 2007 B2
7330270 O'Hara et al. Feb 2008 B2
7336366 Choma et al. Feb 2008 B2
7342659 Horn et al. Mar 2008 B2
7355716 De Boer et al. Apr 2008 B2
7355721 Quadling et al. Apr 2008 B2
7359062 Chen et al. Apr 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382809 Chong et al. Jun 2008 B2
7391520 Zhou et al. Jun 2008 B2
7458683 Chernyak et al. Dec 2008 B2
7530948 Seibel et al. May 2009 B2
7539530 Caplan et al. May 2009 B2
7609391 Betzig Oct 2009 B2
7630083 de Boer et al. Dec 2009 B2
7643152 de Boer et al. Jan 2010 B2
7643153 de Boer et al. Jan 2010 B2
7646905 Guittet et al. Jan 2010 B2
7649160 Colomb et al. Jan 2010 B2
7664300 Lange et al. Feb 2010 B2
7733497 Yun et al. Jun 2010 B2
7782464 Mujat et al. Aug 2010 B2
7805034 Kato et al. Sep 2010 B2
20010036002 Tearney et al. Nov 2001 A1
20010047137 Moreno et al. Nov 2001 A1
20020016533 Marchitto et al. Feb 2002 A1
20020024015 Hoffmann et al. Feb 2002 A1
20020048025 Takaoka Apr 2002 A1
20020048026 Isshiki et al. Apr 2002 A1
20020052547 Toida May 2002 A1
20020057431 Fateley et al. May 2002 A1
20020064341 Fauver et al. May 2002 A1
20020076152 Hughes et al. Jun 2002 A1
20020085209 Mittleman et al. Jul 2002 A1
20020086347 Johnson et al. Jul 2002 A1
20020091322 Chaiken et al. Jul 2002 A1
20020093662 Chen et al. Jul 2002 A1
20020109851 Deck Aug 2002 A1
20020122182 Everett et al. Sep 2002 A1
20020122246 Tearney et al. Sep 2002 A1
20020140942 Fee et al. Oct 2002 A1
20020158211 Gillispie Oct 2002 A1
20020161357 Anderson et al. Oct 2002 A1
20020163622 Magnin et al. Nov 2002 A1
20020168158 Furusawa et al. Nov 2002 A1
20020172485 Keaton et al. Nov 2002 A1
20020183623 Tang et al. Dec 2002 A1
20020188204 McNamara et al. Dec 2002 A1
20020196446 Roth et al. Dec 2002 A1
20020198457 Tearney et al. Dec 2002 A1
20030001071 Mandella et al. Jan 2003 A1
20030013973 Georgakoudi et al. Jan 2003 A1
20030023153 Izatt et al. Jan 2003 A1
20030026735 Nolte et al. Feb 2003 A1
20030028114 Casscells, III et al. Feb 2003 A1
20030030816 Eom et al. Feb 2003 A1
20030043381 Fercher Mar 2003 A1
20030053673 Dewaele et al. Mar 2003 A1
20030067607 Wolleschensky et al. Apr 2003 A1
20030082105 Fischman et al. May 2003 A1
20030097048 Ryan et al. May 2003 A1
20030108911 Klimant et al. Jun 2003 A1
20030120137 Pawluczyk et al. Jun 2003 A1
20030135101 Webler Jul 2003 A1
20030137669 Rollins et al. Jul 2003 A1
20030164952 Deichmann et al. Sep 2003 A1
20030165263 Hamer et al. Sep 2003 A1
20030171691 Casscells, III et al. Sep 2003 A1
20030174339 Feldchtein et al. Sep 2003 A1
20030199769 Podoleanu et al. Oct 2003 A1
20030216719 Debenedictics et al. Nov 2003 A1
20030220749 Chen et al. Nov 2003 A1
20030236443 Cespedes et al. Dec 2003 A1
20040002650 Mandrusov et al. Jan 2004 A1
20040039298 Abreu Feb 2004 A1
20040054268 Esenaliev et al. Mar 2004 A1
20040072200 Rigler et al. Apr 2004 A1
20040075841 Van Neste et al. Apr 2004 A1
20040076940 Alexander et al. Apr 2004 A1
20040077949 Blofgett et al. Apr 2004 A1
20040085540 Lapotko et al. May 2004 A1
20040086245 Farroni et al. May 2004 A1
20040100631 Bashkansky et al. May 2004 A1
20040100681 Bjarklev et al. May 2004 A1
20040110206 Wong et al. Jun 2004 A1
20040126048 Dave et al. Jul 2004 A1
20040126120 Cohen et al. Jul 2004 A1
20040133191 Momiuchi et al. Jul 2004 A1
20040150829 Koch et al. Aug 2004 A1
20040150830 Chan Aug 2004 A1
20040152989 Puttappa et al. Aug 2004 A1
20040165184 Mizuno Aug 2004 A1
20040166593 Nolte et al. Aug 2004 A1
20040189999 De Groot et al. Sep 2004 A1
20040212808 Okawa et al. Oct 2004 A1
20040239938 Izatt Dec 2004 A1
20040246490 Wang Dec 2004 A1
20040246583 Mueller et al. Dec 2004 A1
20040254474 Seibel et al. Dec 2004 A1
20040263843 Knopp et al. Dec 2004 A1
20050004453 Tearney et al. Jan 2005 A1
20050018133 Huang et al. Jan 2005 A1
20050018201 De Boer Jan 2005 A1
20050035295 Bouma et al. Feb 2005 A1
20050036150 Izatt et al. Feb 2005 A1
20050046837 Izumi et al. Mar 2005 A1
20050057680 Agan Mar 2005 A1
20050057756 Fang-Yen et al. Mar 2005 A1
20050059894 Zeng et al. Mar 2005 A1
20050065421 Burckhardt et al. Mar 2005 A1
20050075547 Wang Apr 2005 A1
20050083534 Riza et al. Apr 2005 A1
20050119567 Choi et al. Jun 2005 A1
20050128488 Milen et al. Jun 2005 A1
20050165303 Kleen et al. Jul 2005 A1
20050171438 Chen et al. Aug 2005 A1
20050190372 Dogariu et al. Sep 2005 A1
20050254061 Alphonse et al. Nov 2005 A1
20060033923 Hirasawa et al. Feb 2006 A1
20060093276 Bouma et al. May 2006 A1
20060103850 Alphonse et al. May 2006 A1
20060146339 Fujita et al. Jul 2006 A1
20060155193 Leonardi et al. Jul 2006 A1
20060164639 Horn et al. Jul 2006 A1
20060171503 O'Hara et al. Aug 2006 A1
20060184048 Saadat et al. Aug 2006 A1
20060193352 Chong et al. Aug 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060279742 Tearney Dec 2006 A1
20070019208 Toida et al. Jan 2007 A1
20070038040 Cense et al. Feb 2007 A1
20070070496 Gweon et al. Mar 2007 A1
20070076217 Baker et al. Apr 2007 A1
20070086013 De Lega et al. Apr 2007 A1
20070086017 Buckland et al. Apr 2007 A1
20070091317 Freischlad et al. Apr 2007 A1
20070133002 Wax et al. Jun 2007 A1
20070188855 Shishkov et al. Aug 2007 A1
20070223006 Tearney et al. Sep 2007 A1
20070236700 Yun et al. Oct 2007 A1
20070258094 Izatt et al. Nov 2007 A1
20070291277 Everett et al. Dec 2007 A1
20080002197 Sun et al. Jan 2008 A1
20080007734 Park et al. Jan 2008 A1
20080049220 Izzia et al. Feb 2008 A1
20080094613 de Boer et al. Apr 2008 A1
20080094637 de Boer et al. Apr 2008 A1
20080097225 Tearney et al. Apr 2008 A1
20080097709 de Boer et al. Apr 2008 A1
20080100837 de Boer et al. May 2008 A1
20080152353 de Boer et al. Jun 2008 A1
20080154090 Hashimshony Jun 2008 A1
20080204762 Izatt et al. Aug 2008 A1
20080228086 Ilegbusi Sep 2008 A1
20080265130 Colomb et al. Oct 2008 A1
20080308730 Vizi et al. Dec 2008 A1
20090005691 Huang Jan 2009 A1
20090011948 Uniu et al. Jan 2009 A1
20090196477 Cense et al. Aug 2009 A1
20090273777 Yun et al. Nov 2009 A1
20090290156 Popescu et al. Nov 2009 A1
20100086251 Xu et al. Apr 2010 A1
20100094576 de Boer et al. Apr 2010 A1
20100150467 Zhao et al. Jun 2010 A1
Foreign Referenced Citations (84)
Number Date Country
1550203 Dec 2004 CN
4105221 Sep 1991 DE
4309056 Sep 1994 DE
19542955 May 1997 DE
10351319 Jun 2005 DE
0110201 Jun 1984 EP
0251062 Jan 1988 EP
0617286 Feb 1994 EP
0590268 Apr 1994 EP
0728440 Aug 1996 EP
0933096 Aug 1999 EP
1324051 Jul 2003 EP
1426799 Jun 2004 EP
2738343 Aug 1995 FR
1257778 Dec 1971 GB
2030313 Apr 1980 GB
2209221 May 1989 GB
2298054 Aug 1996 GB
6073405 Apr 1985 JP
20040056907 Feb 1992 JP
4135550 May 1992 JP
4135551 May 1992 JP
5509417 Nov 1993 JP
2002214127 Jul 2002 JP
20030035659 Feb 2003 JP
2007271761 Oct 2007 JP
7900841 Oct 1979 WO
9201966 Feb 1992 WO
9216865 Oct 1992 WO
9219930 Nov 1992 WO
9303672 Mar 1993 WO
9533971 Dec 1995 WO
9628212 Sep 1996 WO
9732182 Sep 1997 WO
9800057 Jan 1998 WO
9801074 Jan 1998 WO
9814132 Apr 1998 WO
9835203 Aug 1998 WO
9838907 Sep 1998 WO
9846123 Oct 1998 WO
9848838 Nov 1998 WO
9848846 Nov 1998 WO
9905487 Feb 1999 WO
9944089 Feb 1999 WO
9944089 Sep 1999 WO
9957507 Nov 1999 WO
0058766 Oct 2000 WO
0101111 Jan 2001 WO
0108579 Feb 2001 WO
0127679 Apr 2001 WO
0138820 May 2001 WO
0142735 Jun 2001 WO
0236015 May 2002 WO
0237075 May 2002 WO
0238040 May 2002 WO
02053050 Jul 2002 WO
02054027 Jul 2002 WO
02084263 Oct 2002 WO
03020119 Mar 2003 WO
03046495 Jun 2003 WO
03046636 Jun 2003 WO
03052478 Jun 2003 WO
03062802 Jul 2003 WO
03105678 Dec 2003 WO
2004034869 Apr 2004 WO
2004057266 Jul 2004 WO
2004066824 Aug 2004 WO
2004088361 Oct 2004 WO
2004105598 Dec 2004 WO
2005000115 Jan 2005 WO
2005047813 May 2005 WO
2005054780 Jun 2005 WO
2005082225 Sep 2005 WO
2006004743 Jan 2006 WO
2006014392 Feb 2006 WO
2006038876 Apr 2006 WO
2006039091 Apr 2006 WO
2006059109 Jun 2006 WO
2006124860 Nov 2006 WO
2006130797 Dec 2006 WO
2007028531 Mar 2007 WO
2007038787 Apr 2007 WO
2007083138 Jul 2007 WO
2007084995 Jul 2007 WO
Related Publications (1)
Number Date Country
20090036770 A1 Feb 2009 US
Provisional Applications (1)
Number Date Country
60287899 May 2001 US
Divisions (1)
Number Date Country
Parent 10137749 May 2002 US
Child 12188623 US